Alexion Pharmaceuticals Inc Quick Ratio (ALXN) starting from the first quarter 2021 to first quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Alexion Pharmaceuticals Inc   (NASDAQ: ALXN)

Alexion Pharmaceuticals Inc 's Quick Ratio

ALXN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Alexion Pharmaceuticals Inc 's Cash & cash equivalent grew by 15.67 % in the Q1 2021 sequentially, while Current Liabilities decreased, this led to improvement in Alexion Pharmaceuticals Inc 's Quick Ratio to 2.43, above Alexion Pharmaceuticals Inc average Quick Ratio.

Within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Alexion Pharmaceuticals Inc in first quarter 2021. While Quick Ratio total ranking in the first quarter 2021 has deteriorated compared to the prior quarter from 1596 to 1843.

Explain Quick Ratio?
How much Cash & cash equivalents ALXN´s has?
What are ALXN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALXN Quick Ratio (Mar 31 2021)
Q1		 (Dec 31 2020)
Q4		 (Sep 30 2020)
Q3		 (Jun 30 2020)
Q2		 (Mar 31 2020)
Q1
Y / Y Current Liabilities Change 27.35 % -22.15 % 21.98 % 8.59 % 18.66 %
Y / Y Cash & cash equivalent Change 46.83 % 9.09 % 3.66 % 36.48 % 42.76 %
Quick Ratio MRQ 2.43 1.85 1.73 2.55 2.11
ALXN's Total Ranking # 1843 # 1596 # 1432 # 1041 # 1731
Seq. Current Liabilities Change -12.22 % 22.07 % 18.83 % 0.02 % -46.34 %
Seq. Cash & cash equivalent Change 15.67 % 30.58 % -19.46 % 20.7 % -14.06 %



Quick Ratio first quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 443
Healthcare Sector # 757
Overall Market # 1843


Quick Ratio Statistics
High Average Low
4.29 2.31 1.13
(Dec 31 2013)   (Jun 30 2018)




Financial Statements
Alexion Pharmaceuticals Inc 's Current Liabilities $ 1,426 Millions Visit ALXN's Balance sheet
Alexion Pharmaceuticals Inc 's Cash & cash equivalent $ 3,469 Millions Visit ALXN's Balance sheet
Source of ALXN's Sales Visit ALXN's Sales by Geography


Cumulative Alexion Pharmaceuticals Inc 's Quick Ratio

ALXN's Quick Ratio for the trailling 12 Months

ALXN Quick Ratio

 (Mar 31 2021)
12 Months		 (Dec 31 2020)
12 Months		 (Sep 30 2020)
12 Months		 (Jun 30 2020)
12 Months		 (Mar 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth 3.23 % 0.82 % 30.57 % 26.91 % 24.46 %
Y / Y Cash & cash equivalent TTM Growth 23.36 % 20.68 % 35.88 % 48.16 % 58.06 %
Quick Ratio TTM 2.11 2.02 1.81 1.88 1.77
Total Ranking TTM # 4789 # 4673 # 4804 # 892 # 4806
Seq. Current Liabilities TTM Growth 5.9 % -8.17 % 4.43 % 1.66 % 3.42 %
Seq. Cash & cash equivalent TTM Growth 10.53 % 2.44 % 0.8 % 8.09 % 8.13 %

Quick ratio ranking by company, industry and sector >> Back to ALXN Financial Strength Comparisons >> Go to Compare ALXN Quick Ratio to its Competitors

On the trailing twelve months basis ALXN Cash & cash equivalent soared by 46.83 % in Q1 2021 year on year, faster than Current Liabilities, this led to increase in in Alexion Pharmaceuticals Inc 's Quick Ratio to 2.11, Quick Ratio remained below ALXN average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 506 other companies have achieved higher Quick Ratio than Alexion Pharmaceuticals Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2020 from 4673 to 4789.

Explain Quick Ratio?
How much Cash & cash equivalents ALXN´s has?
What are ALXN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 507
Healthcare Sector # 992
Within the Market # 4789


trailing twelve months Quick Ratio Statistics
High Average Low
3.77 2.22 0.54
(Dec 31 2013)   (Sep. 30, 2015)




Companies with similar Quick Ratio in the quarter ending Mar 31 2021, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2021 MRQ Cash & cash equivalentMar 31 2021 MRQ Current Liabilities
Chiasma Inc   6.64 $ 115.033  Millions$ 17.319  Millions
Mersana Therapeutics inc   6.54 $ 228.430  Millions$ 34.919  Millions
Spero Therapeutics Inc   6.51 $ 115.676  Millions$ 17.763  Millions
Soligenix inc   6.51 $ 30.542  Millions$ 4.691  Millions
Quantum Cyber N v   6.46 $ 8.728  Millions$ 1.352  Millions
9 Meters Biopharma Inc   6.44 $ 38.571  Millions$ 5.987  Millions
Hookipa Pharma inc   6.35 $ 127.716  Millions$ 20.116  Millions
Madrigal Pharmaceuticals Inc   6.34 $ 307.224  Millions$ 48.471  Millions
Carisma Therapeutics Inc   6.33 $ 109.965  Millions$ 17.367  Millions
Nurix Therapeutics Inc   6.32 $ 303.073  Millions$ 47.972  Millions
Sarepta Therapeutics Inc   6.31 $ 1,737.833  Millions$ 275.492  Millions
Arcus Biosciences Inc   6.26 $ 826.926  Millions$ 132.055  Millions
Tuhura Biosciences Inc   6.21 $ 15.718  Millions$ 2.533  Millions
Panbela Therapeutics Inc   6.18 $ 8.098  Millions$ 1.310  Millions
Igc Pharma Inc   6.18 $ 14.628  Millions$ 2.368  Millions
Ionis Pharmaceuticals Inc   6.17 $ 1,819.995  Millions$ 295.105  Millions
Mirum Pharmaceuticals Inc   6.09 $ 213.113  Millions$ 35.022  Millions
Jazz Pharmaceuticals Plc  5.94 $ 4,530.066  Millions$ 762.396  Millions
Galmed Pharmaceuticals Ltd   5.92 $ 34.815  Millions$ 5.879  Millions
Cypherpunk Technologies Inc   5.88 $ 43.491  Millions$ 7.392  Millions
Nexien Biopharma Inc   5.87 $ 0.031  Millions$ 0.005  Millions
Zymeworks Inc   5.86 $ 411.474  Millions$ 70.245  Millions
Biodexa Pharmaceuticals Plc  5.83 $ 14.481  Millions$ 2.485  Millions
Phathom Pharmaceuticals Inc   5.83 $ 237.974  Millions$ 40.845  Millions
Cns Pharmaceuticals Inc   5.82 $ 11.075  Millions$ 1.902  Millions
Nucana Plc  5.76 $ 67.452  Millions$ 11.716  Millions
Tricida Inc   5.75 $ 217.731  Millions$ 37.864  Millions
Aveo Pharmaceuticals Inc   5.72 $ 121.414  Millions$ 21.217  Millions
Tg Therapeutics Inc   5.66 $ 523.848  Millions$ 92.494  Millions
Entasis Therapeutics Holdings Inc   5.59 $ 44.937  Millions$ 8.033  Millions

Date modified: 2026-09-12T06:12:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.